Identifying optimal tumor-associated antigen combinations with single-cell genomics to enable multi-targeting therapies
Targeted antibody-based therapy for oncology represents a highly efficacious approach that has demonstrated robust responses against single tumor-associated antigen (TAA) targets. However, tumor heterogeneity presents a major obstacle for targeting mos…